2,8-bis(trifluoromethyl)-4-bromoquinoline

Catalog No. :
ACPMET745
CAS No. :
35853-45-3
Molecular Formula :
C11H4BrF6N
Molecular Weight :
344.05

IUPAC Name:4-bromo-2,8-bis(trifluoromethyl)quinoline

2,8-bis(trifluoromethyl)-4-bromoquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$130.00Login to see priceIn stockIn stock
10g98%$229.00Login to see priceIn stockInquiry
25g98%$561.00Login to see priceIn stockInquiry
100g98%$2189.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,8-bis(trifluoromethyl)-4-bromoquinoline
IUPAC Name4-bromo-2,8-bis(trifluoromethyl)quinoline
MDL No.MFCD00075340
Molecular FormulaC11H4BrF6N
Molecular Weight344.05
SMILESFC(C1=C2N=C(C(F)(F)F)C=C(Br)C2=CC=C1)(F)F
InChI KeyDXALAFAFIXJDOS-UHFFFAOYSA-N
SynonymCS-0155815 | AKOS015853172 | BDBM35448 | AB02869 | 4-bromo-2,8-bistrifluoromethylquinoline | SY023885 | 4-Bromo-2,8-bis(trifluoromethyl)quinoline | C11H4BrF6N | cid_4071242 | MFCD00075340 | FT-0610759 | SCHEMBL2790491 | DTXSID60399008 | Quinoline, 4-bromo
CAS No.35853-45-3
PubChem CID4071242

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPMET745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPMET745 route product structure diagram
    ACPMET74535853-45-3 In Stock
Inquiry

2. ACPMET745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPMET745 route product structure diagram
    ACPMET74535853-45-3 In Stock
Inquiry

Comments (0)